Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.
Authors : de Bakker T, Journe F, Descamps G, Saussez S, Dragan T, Ghanem G, Krayem M, Van Gestel D Year : 2022 Journal : Front Oncol
Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.
Authors : Yanni A, Buset T, Bouland C, Loeb I, Lechien JR, Rodriguez A, Journe F, Saussez S, Dequanter D Year : 2022 Journal : Eur Arch Otorhinolaryngol
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.
Authors : Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE Year : 2022 Journal : Cells
Survival and treatment outcome of head and neck cancer patients with pulmonary oligometastases.
Authors : Lardinois I, Dequanter D, Lechien JR, Bouland C, Javadian R, Rodriguez A, Loeb I, Journe F, Saussez S Year : 2021 Journal : Clin Otolaryngol
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Authors : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F Year : 2021 Journal : Mol Cancer Res